About the Company:

Prema Cognition (PREMAZ) is a health technology company developing tools for the early detection and monitoring of cognitive decline and dementia. Founded by medical doctor Julia Cooney and developed in collaboration with the University of Cambridge Memory Lab, PREMAZ aims to shift dementia care from late-stage treatment to earlier detection and prevention.

Our core product is a precision memory assessment, a scalable digital cognitive test designed to detect subtle changes in cognitive function and track them over time.

PREMAZ works with a range of partners across healthcare and research, including neurology and GP clinics, longevity clinics, pharmaceutical and biotech research organisations, and care providers such as nursing homes and assisted living facilities.

PREMAZ is venture-backed and recently closed its first external funding round to support the next phase of product development and clinical partnerships.

<...